Enea: Virus-resistant Software
Redeye trims the short-term estimates due to the general economic calamity in the wake of Covid-19. However, we keep our valuation as we reckon that Enea's defensive software business is resilient and to a large extent seems unaffected by the adversities of the coronavirus. Most notably, the recurring revenue ratio is above 50%.